ArticleTrials2022

A randomized, double-blind, placebo-controlled, hybrid parallel-arm study of low-dose naltrexone as an adjunctive anti-inflammatory treatment for major depressive disorder.

Julia R Plank et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.